Clinical Trial Update: Total Marrow Irradiation and High-dose Melphalan for Double Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma [Phase 2]

View source ↗

Summary

Clinical trial update for total marrow irradiation with high-dose melphalan as conditioning before double autologous stem cell transplantation in multiple myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN